| scholarly article | Q13442814 |
| P2093 | author name string | Hoff J | |
| Raffi F | |||
| Gassin M | |||
| Bani-Sadr F | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis B virus | Q6844 |
| chronic hepatitis B | Q55779876 | ||
| chronic hepatitis | Q62019625 | ||
| lamivudine | Q422631 | ||
| P304 | page(s) | 963-969 | |
| P577 | publication date | 2001-03-07 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Evaluation of chronic hepatitis B virus (HBV) infection in coinfected patients receiving lamivudine as a component of anti-human immunodeficiency virus regimens | |
| P478 | volume | 32 |
| Q33883722 | Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection |
| Q36932959 | Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection |
| Q45711101 | BHIVA Guidelines: coinfection with HIV and Chronic hepatitis B virus |
| Q40406133 | BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis B virus infection (2005). |
| Q34002160 | Chronic hepatitis B. |
| Q35071452 | Clinical and virological aspects of hepatitis B co-infection in individuals infected with human immunodeficiency virus type-1. |
| Q36327100 | Complications in treating chronic hepatitis B in patients with HIV. |
| Q35917541 | Current therapies for chronic hepatitis B virus infection |
| Q44671785 | Dynamics of plasma hepatitis B virus levels after highly active antiretroviral therapy in patients with HIV infection |
| Q94328073 | Emtricitabine for adults with lamivudine‐resistant chronic hepatitis B virus infection |
| Q36478120 | Established and emerging therapies for the treatment of viral hepatitis |
| Q44355838 | Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1. |
| Q34950625 | HIV-1 infection in injection drug users |
| Q36140666 | HIV-1/hepatitis B coinfection |
| Q46188049 | Hepatitis B in patients with HIV infection |
| Q34405008 | Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review. |
| Q33315735 | Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil |
| Q35007583 | Hepatitis B virus resistance to lamivudine and its clinical implications |
| Q36153966 | KASL Clinical Practice Guidelines: Management of chronic hepatitis B. |
| Q26752475 | KASL clinical practice guidelines: management of chronic hepatitis B |
| Q41338162 | Lack of an effect of human immunodeficiency virus coinfection on the pharmacokinetics of entecavir in hepatitis B virus-infected patients |
| Q34364620 | Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand |
| Q37772508 | Management of HIV and hepatitis virus coinfection |
| Q35757754 | Management of hepatitis B in patients coinfected with the human immunodeficiency virus. |
| Q36141221 | Management of patients co-infected with hepatitis B virus and HIV. |
| Q45410594 | Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations |
| Q33716290 | Predictors of loss of hepatitis B surface antigen in HIV-infected patients |
| Q38406226 | Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras |
| Q33525046 | The effect of human immunodeficiency virus on hepatitis B virus serologic status in co-infected adults |
| Q37754603 | Treatment of chronic hepatitis B: efficacy of current drugs and prospects for the future |
| Q58646483 | Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response |
| Q50190669 | Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance |
Search more.